Please wait while the formulary information is being retrieved.
HYDRALAZINE HCL (HYDRALAZINE HCL)
- Hypertension
hydralazine 20 mg/mL injection solution
- Dosage information is not available
Hypertension
- Inject 0.5 milliliter (10 mg) by intramuscular route every 2 hours not to exceed 40 mg in 24Hrs
- Inject 0.5 milliliter (10 mg) by intravenous route every 4 hours as needed
- Inject 0.5 milliliter (10 mg) by intravenous route every 6 hours as needed
- Inject 0.5 milliliter (10 mg) by intravenous route every 4-6 hours asneeded
- Inject 0.5 milliliter (10 mg) by intramuscular route every 4-6 hours as needed
- Inject 0.5 milliliter (10 mg) by intramuscular route every 6 hours asneeded
- Inject 0.5 milliliter (10 mg) by intramuscular route every 4 hours asneeded
- Inject 1 milliliter (20 mg) by intramuscular route every 4 hours as needed
- Inject 1 milliliter (20 mg) by intramuscular route every 6 hours as needed
- Inject 1 milliliter (20 mg) by intramuscular route every 4-6 hours asneeded
- Inject 1 milliliter (20 mg) by intravenous route every 4-6 hours as needed
- Inject 1 milliliter (20 mg) by intravenous route every 4 hours as needed
- Inject 1 milliliter (20 mg) by intravenous route every 6 hours as needed
- Inject 2 milliliters (40 mg) by intravenous route every 6 hours as needed
- Inject 2 milliliters (40 mg) by intravenous route every 4 hours as needed
- Inject 2 milliliters (40 mg) by intravenous route every 4-6 hours as needed
- Inject 2 milliliters (40 mg) by intramuscular route every 4-6 hours as needed
- Inject 2 milliliters (40 mg) by intramuscular route every 6 hours as needed
- Inject 2 milliliters (40 mg) by intramuscular route every 4 hours as needed
- None
Contraindicated
- None
Severe
Moderate
- Dutoprol
- Inderal La
- Inderal Xl
- Innopran Xl
- Lopressor
- Lopressor Hct
- metoprolol su-hydrochlorothiaz
- metoprolol succinate
- metoprolol ta-hydrochlorothiaz
- metoprolol tartrate
- propranolol
- propranolol-hydrochlorothiazid
- Toprol Xl
- None
Contraindicated
- 30 day risk period post-myocardial infarction
- Coronary artery disease
- Hypotension
- Hypovolemia
- N-acetyltransferase slow acetylator
Severe
Moderate
- Cerebrovascular accident
- Intracranial hypertension
- Lupus-like syndrome
HYDRALAZINE HCL (HYDRALAZINE HCL)
- Hypertension
- None
- Anorexia
- Diarrhea
- Headache disorder
- Nausea
- Palpitations
- Tachycardia
- Vomiting
More Frequent
Severe
Less Severe
- Angina
- Edema
- Lupus-like syndrome
- Peripheral neuropathy
- Pruritus of skin
- Skin rash
- Urticaria
- Constipation
- Dizziness
- Dyspnea
- Eye tearing
- Flushing
- Hypotension
- Nasal congestion
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Agranulocytosis
- Anemia
- Eosinophilia
- Glomerulonephritis
- Hepatitis
- Leukopenia
- Lymphadenopathy
- Neutropenic disorder
- Paralytic ileus
- Purpura
- Splenomegaly
Less Severe
- Acute confusion
- Arthralgias
- Chills
- Conjunctivitis
- Depression
- Dysuria
- Fever
- Peripheral neuritis
- Symptoms of anxiety
- Tremor
Contraindicated
None
Severe Precaution
None
Management or Monitoring Precaution
None
Hydralazine
- Severity Level:
C
- Additional Notes:
Contraindicated
None
General | Excretion Potential | Effect on Infant | Notes |
None |
Precaution Exists
None
General | Excretion Potential | Effect on Infant | Notes |
None |
No Known Risk
Hydralazine
Limited data suggest infant exposure is minimal with no adv effects
General | Excretion Potential | Effect on Infant | Notes |
No known risks; does not adversely affect lactation | Excreted | Not known; no or inclusive data | Limited data suggest infant exposure is minimal with no adv effects |
Contraindicated
None
Precaution Exists
Hydralazine
Cardiovascular-Elderly are more sensitive to hypotensive effects. Other-More sensitive to drug-induced hypothermia.
Organ / System | HEP | REN | CARD | ENDO | NEURO / PSYCH | PULM |
Increased Risk / Adverse Effects | Y | N | Y | N | N | N |
BEERS: N HEDIS: N STOPP: Y
No Known Risk
None
- None
Hypertension | |
I10 | Essential (primary) hypertension |
I11 | Hypertensive heart disease |
I11.0 | Hypertensive heart disease with heart failure |
I11.9 | Hypertensive heart disease without heart failure |
I12 | Hypertensive chronic kidney disease |
I12.0 | Hypertensive chronic kidney disease with stage 5 chronic kidney disease or end stage renal disease |
I12.9 | Hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease |
I13 | Hypertensive heart and chronic kidney disease |
I13.0 | Hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease |
I13.1 | Hypertensive heart and chronic kidney disease without heart failure |
I13.10 | Hypertensive heart and chronic kidney disease without heart failure, with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease |
I13.11 | Hypertensive heart and chronic kidney disease without heart failure, with stage 5 chronic kidney disease, or end stage renal disease |
I13.2 | Hypertensive heart and chronic kidney disease with heart failure and with stage 5 chronic kidney disease, or end stage renal disease |
I15.1 | Hypertension secondary to other renal disorders |
0-9 | A-Z |
---|---|
I10 | Essential (primary) hypertension |
I11 | Hypertensive heart disease |
I11.0 | Hypertensive heart disease with heart failure |
I11.9 | Hypertensive heart disease without heart failure |
I12 | Hypertensive chronic kidney disease |
I12.0 | Hypertensive chronic kidney disease with stage 5 chronic kidney disease or end stage renal disease |
I12.9 | Hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease |
I13 | Hypertensive heart and chronic kidney disease |
I13.0 | Hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease |
I13.1 | Hypertensive heart and chronic kidney disease without heart failure |
I13.10 | Hypertensive heart and chronic kidney disease without heart failure, with stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease |
I13.11 | Hypertensive heart and chronic kidney disease without heart failure, with stage 5 chronic kidney disease, or end stage renal disease |
I13.2 | Hypertensive heart and chronic kidney disease with heart failure and with stage 5 chronic kidney disease, or end stage renal disease |
I15.1 | Hypertension secondary to other renal disorders |
Formulary Reference Tool